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Summary-The effects of various cholinergic agonists and antagonists and their interactions 
were determined on the awake-sleep cycle of cats with chronic indwelling brain electrodes. 
The effects were measured by the use of the EEG and correlated with gross behavioral observa- 
tion. EEG recordinxs were taken from various neocortical and limbic structures, ~cluding 
the amygdala and hi~pocampus. 
EEG activation and behavioral arousal following acetylcholine (0’007 mg/kg) intra- 
venously was blocked by pretreatment with the muscarinic (m) choline& antagonists methyl 
atropine and atropine (@3 mg/kg). On the other hand this was not affected by the nicotinic (n) 
ganglionic cholin&ic antagonists trimethidinium (1 mg/kg) and mecamylamine (@7 mg/kp). 
EEG activation and behavioral arousal produced by arecoline (@4 mg/kg) was reduced slightly 
by methyl atropine and completely bl&ked by at&pine, but not modified by trimethidinium 
and mecamylamine. EEG activation and behavioral arousal produced by pilocarpine 
(O-15 mg/kg) was significantly reduced by methyl atropine and almost completely abolished 
by atropine. On the other hand, EEG activation produced by pilocarpine was not signifi- 
cantly blocked by the n choline@ antagonists. Pilocarpine caused a significant increase in 
the duration of fast wave sleep. It also produced an interesting phenomenon in which fast 
wave sleep frequently started from the resting state or followed a short drowsy period in 
contrast to its usual initiation from slow wave sleep. EEG activation and behavioral arousal 
were observed following physostigmine. These effects were reduced by methyl atropine and 
almost completely blocked by atropine. The n cholinergic antagonists did not show any 
significant effect on physostigmine-induced EEG activation and behavioral arousal. Fast 
wave sleep following physostigmine was also occasionally observed starting from the drowsy 
state. There was no increase in fast wave sleep in comparison to saline solution injection 
within 5’0 min following physostigmine. EEG activation and behavioral arousal were pro- 
duced by nicotine (002 mg/kg). These effects were not altered significantly by methyl atropine, 
but moderately reduced by atropine. In addition, atropine produced a dissociation in which 
nicotine-induced EEG activation of the neocortex was still evident although hippocampal and 
amvndaloid activation were blocked. The EEG actions of nicotine were slightly reduced by 
tr~~~~idi~um and completely blocked by the admi~stration of mecamyl&ne. 
It is concluded that this study provides additional evidence for the role of m and n gang- 
lionic cholinergic mechanisms in EEG activation of neocortical and limbic structures. 
INTRODUCTION 
A GREAT deal of evidence implicates cholinerg~c mechanisms in EEG activation. RINALDI 
and HIMWICH (1955) suggested that the mesodiencephalic system of rabbits was cholinergic. 
Since then a number of investigators using a variety of animais have obtained supporting 
data. The Russian pharmacologists DENISENKO (1961, 1962), ILYUTCHENOK and co- 
workers (1961, 1962), MIKHELSON (1961), VALDMAN (1961, 1963) and others have presented 
considerable evidence for the presence of muscarinic (m) and nicotinic ganglion&z (n) 
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receptor mechanisms in neocortical EEG activation. Our own data with nicotine (KNAPP 
and DOMINO, 1962; and YAMAMOTO and DOMINO, 1965), nicotine and arecoline (VILLARREAL 
and DOMINO, 1964) and related cholinergic agonists have led us to similar conclusions. 
Especially pertinent is the research of WIIUER (1952), BRADLEY and ELKES (1957), and 
BRADLEY and NICHOLSON (1962) in which dissociation between the EEG and behavioral 
manifestations of atropine and physostigmine were reported. It was our purpose to study 
a series of choline@ agonists and antagonists on EEG activating mechanisms of neo- 
cortical and limbic system structures in cats with chronic indwelling brain electrodes. 
This manuscript describes the results obtained. A preliminary report of some of the data 
(DOMINO et al., 1967) recently has been published. 
METHODS 
Experiments were performed in eight adult cats of both sexes with chronic indwelling 
brain electrodes. An incomplete Latin Square design was used for drug administration 
at 1 week intervals. The animals were prepared for placement of the brain electrodes 
using modifications of conventional techniques. Surgical preparation of the animals 
was under pentobarbital sodium anesthesia. Stainless steel wires of 0.22 mm dia. 
(insulated except for the tips of 0.5 mm) were used as the depth electrodes. Bipolar depth 
electrodes were inserted into the amygdala and hippocampus with the aid of the stereo- 
taxic atlases of JASPER and AJMONE-MARSAN (1954), and SNIDER and NIEMER (196 1). Physio- 
logic recordings of the injury discharges were used for localization of the hippocampus, 
and olfactory induced waves for the amygdala. Bipolar silver ball electrodes of O-5 mm 
dia. were applied on the epidural surface of the somatosensory cortex. Additional 
depth electrodes were placed occasionally in the posterior hypothalamus and mesen- 
cephalic reticular formation. Each electrode was soldered to a Cannon plug and fixed 
on the calvarium by means of dental cement. Silastic tubing of O-7 mm dia. was inserted 
in the right jugular vein with the other end fixed to the connector on top of the skull. 
The animals were allowed to recover for a 2-week period before being used for the drug 
studies. In the meantime they were given antibiotics prophylactically to reduce infection. 
Each animal was given one of the test pretreatment drugs at weekly intervals throughout 
the entire study. The short acting choline@ agonists such as acetylcholine, nicotine, 
pilocarpine, etc., were tested in a random sequence following recovery from the previous 
drug injection. Thus a variable interval after pretreatment of 20-260 min elapsed. The 
actual times after injection are given for each experimental record showing typical drug 
interactions. The overall mean data were in agreement with these typical trends. At 
the time of the experiment, the EMG of the posterior neck muscles, EKG and respiratory 
movements were recorded along with brain waves on a Grass polygraph. During the 
experimental session each animal was placed in a soundproof box with a one way viewing 
window. Behavior changes were observed and correlated with EEG activity. In order 
to promote natural sleep the animals were made as warm and as comfortable as possible. 
With care and patience it was possible to observe all stages of sleep. 
The following drugs were administered as an i.v. infusion in physiological saline solution 
over a I-min period: acetylcholine chloride, arecoline hydrochloride, atropine sulfate, 
atropine methylnitrate, pilocarpine hydrochloride, physostigmine salicylate, mecamyl- 
amine hydrochloride, and trimethidinium methosulfate. Dosage of all drugs was calcu- 
lated as base and given in a volume of I.5 ml. After completion of the experiments the 
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position of the electrodes was determined histolo~~ally by the iron deposition technique 
(see DOMINO, 1955, for details). Blood pressure was measured in acute animals prepared 
under diethyl ether anesthesia and subsequently given a local anesthetic, 1 mgfkg of decame- 
thonium and artificial respiration at 300 ml of air/kg/min. 
RESULTS 
Lack of effects of saline inf~ion on EEG and ~ehavior 
Six different EEG levels can easily be recorded in the chronic cat: excited, alert, resting, 
drowsy, slow wave and fast wave (activated) sleep. As illustrated in Fig. 1 these EEG 
states are identified by specific alterations of neocortical and limbic system spontaneous 
activity. In addition, on the basis of EKG, ocular movements and EMG, the states can 
be further differentiated. All animals given an i.v. infusion of 1.5 ml of physiologic saline 
solution warmed to body temperature did not show any change in EEG and behavior. 
Ejects of vario~ chol~nergi~ antagonists on the uwake-sleep cycle 
(1) Atropine sulfate. Depending upon dose, atropine either had no sign&ant effect 
(less than 0.1 mg/kg, i.v.), facilitated slow wave sleep (O-3 mg/kg) or prevented natural 
fast wave sleep and caused behavioral hyperexcitability with continuous EEG slow waves 
(over 0.6 mg/kg). The latter phenomenon of EEG dissociation from overt behavior was 
similar to that reported by WIKLER (1952), BRADLEY and ELKES (1957), and BRADLEY and 
NICHOLSON (1962). A dose of O-3 mg/kg of atropine was chosen as the amount for pre- 
treatment to study its interaction with various cholinergic agonists. This dose of atropine 
reduces but does not completely block the depressor response to i.v. choline&c agonists. 
(2) Methyl atropine. In contrast to the marked effects of atropine on EEG and 
behavior, methyl atropine had much less effect. Doses below 0.6 mg/kg did not modify 
the awake-sleep cycle of the cat. However, obvious peripheral physiological manifesta- 
tions were noted, including dilated pupils and tachycardia. Inasmuch as a dose of 0.3 
mg/kg of atropine was used, a similar dose of methyl atropine was chosen to study its 
interaction with choline+ agonists. 
(3) ~e~amylamine. The spontaneous awake-sleep cycle of the chronic cat was not 
afIected by doses of mecamylamine below O-7 mgjkg i.v. On the other hand doses larger 
than 1 mg/kg of mecamylamine interfered with the EEG and behavioral manifestations 
of slow wave sleep. Usually the cat lay on the floor of the observation chamber and would 
not fall asleep. Therefore, a dose of 0.7 mg/kg was chosen in order to study its interaction 
with various choline@ agonists. 
(4) Tr~methidinium. Relatively large doses of ~rne~id~iurn had no significant effect 
on the EEG. Doses below 1 mg/kg i.v. did not interfere with the awake-sleep cycle but 
did produce tachycardia. Doses larger than 2 mgjkg caused the animal to lie on its side 
on the floor of the cage, and to continue to manifest signs of normal sleep. It was decided 
to use a dose of 1.0 mg/kg of trimethidinium as the pretreatment dose to study its inter- 
action with cholinergic agonists. 
Interactions of various cholinergic agonists-antagonists on the awake-sleep cycle 
(I) Acetylchoiine. Increasing doses of acetylcholine were administered until charac- 
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dose of O-007 mg/kg. With this dose of acetylcholine the blood pressure in decamethonium- 
immobilized cats fell approximately 70 mm Hg. Acetylcholine injection caused behavioral 
arousal such as opening of the eyes, raising and shaking of the head, etc. in animals who 
were previously in slow wave sleep. Some cats violently scratched their neck during the 
period of arousal. Heart and respiratory rates were markedly increased. 
Figure 2 is a graphic illustration of the effect of such a large dose of acetylcholine 
injected i.v. to a sleeping cat. It can be seen that acetylcholine caused a very marked 
change in respiration, heart rate, a transient period of behavioral arousal and EEG activa- 
tion which lasted approximately 4 min. In a series of cats the mean duration Jr S.E. of 
the acetylcholine-induced EEG activation was 4-l f 0.5 min (Table 1). 
In Fig. 3 are illustrated graphically the effects of acetylcholine in the same cat as modified 
FIG. 2. Graph of the effects of acetylcholine. 
TABLE 1. MEAN DURATION f S.E. IN min OF EEG ACTIVATION FOLJBWING VARIOUS CHOLINERGIC AGONISTS- 
ANTAGONISTS GNEN i.v. 
Agonist 
Antagonist Acetylcholine Arecohne Pilocarpine Physostigmine Nicotine 
no. of cats 0.007 mg/kg 0.04 mg/kg 0.15 mg/kg 0.05 mg/kg 0.02 mg/kg 
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by various cholinergic antagonists. It can be seen that methyl atropine completely blocked 
the effects of acetylcholine on both EEG and behavior. The reduction in EEG activation 
was highly significant (P -C OWl). Equal doses of atropine also markedly reduced acetyl- 
choline-induced EEG activation. The reduction of the EEC activation response of acetyl- 
choline by atropine was highly significant (P < OMl, Table 1). 
In contrast to the marked effect of m cholinergic antagonists, n ganglionic cholinergic 
antagonists were completely ineffective in preventing EEG activation and behavioral 
arousal induced by acetylcholine. Of some interest is the finding that acetylcholine-induced 
EEG activation following mecamylamine premeditation was slightly but significantly 
increased (P < 0.05, Table 1). 
(2) Arecoline. A dose of 0.04 mg/kg of arecoline iv. was found to cause approximately 
the same decrease in blood pressure as 0.007 mg/kg of acetylcholine in decamethonium- 
immobilized cats. This dose of arecoline caused behavioral excitement such as elevation 
of the animal’s head, standing up, looking around and walking within a few set after 
injection. The typical EEG and physiological effects of arecoline are illustrated in Fig. 4. 
ARECOLINE @04mg/hg ix 
150 -z50 - 
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FIG. 4. Graph of the effects of arecoline. 
Shortly after injection during slow wave sleep, arecoline produced marked behavioral 
arousal and EEG activation which lasted appoximately 12 min. In a total of eight cats 
the mean duration rt SE. of arecoline induced EEG activation was 11.9 f 0.8 min (Table 
1). Subsequently, the cats lapsed into the drowsy and slow wave sleeping state. Heart 
rate increased. At the same time other autonomic responses such as salivation and slight 
mydriasis were observed. The EEG usually activated prior to behavioral arousal. This 
was particularly evident in the hippocampal lead which showed marked #zeta wave activity. 
The effects of m cholinergic antagonists on the actions of arecoline are plotted graphic- 
ally for the same cat in Fig. 5. After premeditation with methyl atropine, characteristic 
EEG activation was reduced slightly, but the reduction was not statistically sign&ant 
(Table 1). In contrast to the relative lack of effects of methyl atropine, atropine itself 
produced almost complete blockade of the EEG and behavioral manifestations of are- 















































































































































Cholinergic neocortical and Iimbic EEG activation 365 
EEG activation, t~methidinium and m~amyla~ne had no significant effects (Fig. 5 and 
Table 1). 
(3) Pilocarpine. Doses of 0.15 mg/kg of pilocarpine caused EEG activation of approxi- 
mately the same duration as that produced by 0.04 mg/kg of arecoline. This dose of 
pilocarpine produced less hypotension than arecoline. After administration of pilocarpine 
to the cat in slow wave sleep, evident behavioral arousal such as picking up the head, 
standing and walking were observed. At the same time slight mydriasis, salivation and 
lac~mation were present. The drug produced EEG and ~havioral arousal for appro~mately 
13 min which was accompanied by an initial bradycardia, subsequent tachycardia and 
tachypnea (Fig. 6). EEG activation was seen in all leads with particularly prominent 
PILOCARPINE 
DROWSY - 
FJIG. 6. Graph of the effects of pilocarpine. 
hippocampal theta waves. In eight cats the mean duration & SE. of pilocarpine-indu~d 
EEG activation was 13.3 f l-3 min (Table 1). Subsequently, the cats lapsed into the 
resting state. Surprisingly, fast wave sleep sometimes appeared right after the resting 
state. Within 25 min after injection the duration of fast wave sleep increased significantly 
compared with saline controls (P -=c 0.05). In Fig. 7 are illustrated graphically the effects 
of various pretreatments on pilocarpine-induced EEG activation and other vital signs in the 
same cat. It can be observed that the effects of pilocarpine were markedly reduced by 
methyl atropine although EEG activation was still evident. The mean duration f S.E. of 
pilo~arpine-induced EEG activation responses in six eats was reduced to 2.3 i O-2 min 
(P < O-001, Table 1). The induced bradycardia, tachycardia, tachypnea, mi~turition, sali- 
vation, etc. were completely blocked. In contrast to methyl atropine, atropine completely 
prevented the blood pressure, EEG and behavioral manifestations of pilocarpine. On the 
other hand the n ganglionic cholinergic antagonists trimethidinium and mecamylamine did 
not decrease the duration of EEG activation. In fact following mecamylamine the duration 
of EEG activation was significantly increased (P --c 0.01, Table 1). 
(4) Phy~ostig~ine. This compound in a dose of O-05 mg/kg produced significant EEG 
and behavioral arousal. This dose did not interrupt slow wave sleep immed~tely. The 
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activation occurred 8-16 min after i.v. administration. Behaviorally the cat awakened, 
picked up his head, looked around and showed evident mydriasis. The response to external 
stimuli such as noise was exaggerated. Heart rate and respiratory movements increased 
in relationship to the degree of behavioral arousal and EEG activation. The effects of 
physostigmine are illustrated as a graphic plot in Fig. 8. Approximately 25 to 30 min 
following drug injection the cat returned toward a normal state behaviorally, although 
EEG activation persisted for 31.6 -& 2.2 min. After physostigmine the drowsy state was 




J?IG. 8. Graph of the effects of physosti~ine. 
Note the latency before EEG and behavioral arousal following physostigmine. Approxi- 
mately 48 min after injection fast wave sleep began from the drowsy state. 
sometimes followed by fast wave sleep, although no significant increase in fast wave sleep 
was noted within 50 min after i.v. injection. 
Figure 9 illustrates the effects of pretreatment with m cholinergic antagonists on physo- 
stigmine activation in the same cat. After methyl atropine, EEG and behavioral arousal 
produced by physostigmine was still present but significantly reduced. The mean duration 
of EEG activation f S.E. was reduced to 22.9 & 3-2 min (P < 0.05, Table 1). In contrast 
atropine markedly reduced physostigmine-induced EEG activation and behavioral arousal. 
During the peak effect of physosti~ine, approximately 16 min after i.v. injection, the 
amount of slow wave sleep was decreased. However, the animals still showed a drowsy 
pattern. Physostigmine-induced EEG activation following atropine pretreatment was 
markedly reduced to 1.3 f O-5 min (P < OWl, Table 1). In contrast to the effectiveness 
of m cholinergic antagonists, the n ganglionic cholinergic antagonists trimethidinium and 
mecamylamine did not significantly alter the EEG or behavioral manifestations of physo- 
stigmine in the same cat (Fig. 10 and Table 1). 
(5) Nicoline. The i.v. injection of small doses of 0.02 mg/kg of nicotine caused con- 
sistent EEG activation and behavioral arousal. The mean duration f S.E. of nicotine- 
induced EEG activation in eight cats was 4-7 -& 0.5 min. Subsequently, the animals fell 
into slow wave and/or fast wave sleep. The effects of nicotine on the awake-sleep cycle 
of the cat are illustrated graphically in Fig. 11. Marked respiratory stimulation and EKG 
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FIG. 9. Modification of the effects of physostigmine by m choline@ antagonists. 
Note that the effects of physostigmine were reduced slightly by methyl atropine, but blocked 
by atropine. 
alterations were noted during the brief period of EEG and behavioral activation. The 
effects of pretreatment with various cholinergic antagonists on the nicotine-induced 
responses are plotted graphically in Fig. 12. After methyl atropine, nicotine-induced tachypnea 
and tachycardia were still evident. On the other hand nicotine-induced bradycardia was 
blocked. EEG and behavioral arousal due to nicotine was not reduced significantly 
(Table 1). The effects of atropine pretreatment were somewhat similar to those of methyl 
atropine for nicotine-induced neocortical desynchronization and behavioral arousal. 
EEG neocortical desynchronization was reduced slightly but was still clearly evident. 
In contrast, hippocampal and amygdaloid activation patterns were not as clearly present, 
and frequently were dissociated from neocortical desynchronization. Atropine pretreat- 
ment reduced the mean duration f S.E. of nicotine-induced neocortical activation to 
2-l & O-3 min. This effect was statistically significant (P < 0.01). As reported previously 
(YAMAMOTO and DOMINO, 1965) the n cholinergic blockers, mecamylamine and trimethi- 
dinium, showed differential effects. Trimethidinium caused a slight reduction in nicotine 
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FIG. 10. Lack of significant modification of physostigmine effects by n ganglionic choli- 
nergic antagonists. 




FIG. 11. Graph of the effects of nicotine. 
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NICOTINE O-32 mdkg ix. 
INE 002 mg/M Iv 
175 MfN AFTER 
ATR5PlNE SULFATE 
t 
FllCOTlNE 002 mphg iv. 
200 MIN AFTER 
TRIMETHIOINIUM 
I mQ/hg i.v. 
t 
NICOTINE 0.02 mglkgiv. 
212 MIN AFTER 
~~&M~~l~& 
Off mg f&j i-v. 
FIG. 12. Modification of the effects of nicotine by various cholinegic antagonists. 
Note that the EEG effects of nicotine were not blocked by methyl &opine, atropine and 
trimethidinium, but were completely blocked by mecamylamine. 
induced EEO and behavioral activation, In contrast, mecamylamine completely blocked 
the actions of nicotine (Fig, $2 and Table I). 
As reported previously (YAMAMOTO, 1959), the stage of fast wave sleep usually is pre- 
ceded by slow wave sleep. During the present study it was observed that particularly 
following the administration of pilocarpine and physostigmine, this regular sequence 
from sIow wave to fast wave sleep was altered. Frequently after these m cholinergic 
agonists the stage of fast wave sleep started from the resting or drowsy state. In one cat, 
given a massive dose of 1 mgfkg of pilocarpine, fast wave sleep began from the awake 
stage without any intermediate slow wave stage. The duration of fast wave sleep also was 
significantly increased following pifocarpine in doses of 0~15 mg/kg (P < 0.05). During 
the recovery phase, after the long period of EEG activation and behavioral arousal caused 
by physostigmine, fast wake sleep was occasionally seen starting from the drowsy staFe* 
For 50 min following physostigmine there was no increase in duration of fast wave sleep 
over saIine injection. 
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The common observation of a dissociation between EEG and gross behavior was also 
seen in this study. This was especially evident after atropine and physostigmine. Of 
special importance was the fact that in this investigation the cholinergic agonists were 
always given i.v. when the cats were in obvious slow wave sleep as identified by the EEG 
and gross behavior. Shortly thereafter the EEG activating effects of the various cholinergic 
agonists were accompanied by gross behavioral arousal. EEG dissociation from gross 
behavior was usually seen during this early phase or subsequently during recovery. In 
some cases, especially after physostigmine and pilocarpine, the cats lapsed into fast wave 
sleep. Without limbic EEG and polygraphic recordings of EMG, heart rate and respira- 
tion, it would have been difficult to define at least one aspect of EEG dissociation from 
gross behavior, namely fast wave sleep. 
DISCUSSION 
The purpose of this research was to test several hypotheses: (1) That the EEG desyn- 
chronizing effects of various m and II cholinergic agonists were accompanied by behavioral 
arousal, or (2) such EEG desynchronization represented a stage of fast wave sleep and 
(3) by the use of various m and n cholinergic antagonists with differential abilities to pene- 
trate the blood-brain barrier, it would be possible to conclude whether the actions of 
various cholinergic agonists were primarily central or peripheral. There are considerable 
sources of error in this method of research. Perhaps the most important criticism is that 
any study of agonist-antagonist interactions should be quantitative and involve dose- 
response relationships. It has been pointed out by TRENDELENBERG (1963) that false con- 
clusions can be drawn in studies in which single doses of agonists and antagonists are 
used. In view of the lack of a simple and meaningful method for quantifying EEG activity, 
no direct dose-effect relationships were obtained. In this study the doses of various 
cholinergic agonists used produced nearly maximal EEG and behavioral manifestations. 
In contrast, the doses chosen for the cholinergic antagonists did not significantly interfere 
with the awake-sleep cycle of the cat. It should be noted that the doses chosen for the 
various antagonists were insufficient to block completely peripheral autonomic effects such 
as alteration in blood pressure or heart rate. Another objection to the experimental design 
is the variable interval of 20-260 min after pretreatment with a cholinergic antagonist. 
This objection is not valid in the case of long-acting drugs such as trimethidinium. How- 
ever, with the shorter acting antagonists it is obvious they cannot have the same degree 
of effect from 20-260 min after injection. The cholinergic agonists were given in a random 
time interval after pretreatment and somewhat similar effects were obtained, indicating 
that the choline@ antagonists were still active. Since maximal peripheral blocking 
doses could not be given because of induced alterations in the sleep cycle, these results 
should be interpreted as indicating relative degrees of central vs. peripheral blockade. 
In spite of these limitations several predictions were confirmed experimentally. Acetyl- 
choline is a highly charged molecule that should not easily penetrate the blood-brain 
barrier. Its actions on EEG activation and behavioral arousal should be primarily peri- 
pheral in origin. These effects should be blocked by atropine and methyl atropine equally 
well. This in fact was shown. The fact that such small doses of methyl atropine did not 
completely antagonize the peripheral cardiovascular effects of acetylcholine while blocking 
the EEG effects indicates that the EEG effects must be primarily peripheral in origin. 
C 
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These data are in agreement with the findings of NAKAO et al. (1956) that the EEG effects 
of iv. acetylcholine are greatly reduced by sine-aortic denervation. Cholinergic agonists 
and antagonists which easily penetrate the blood-brain barrier on the basis of being less 
highly charged should have both central as well as peripheral actions. It is well recognized 
that the blood-brain barrier is not absolute, Although PAUL DAVID et al. (1960) have 
shown that methyl atropine in sufhcient amount produces EEG slow waves, the doses 
chosen in this study were clearly below those for significant central actions. The actions 
of the various m cholinergic agonists such as acetylcholine, arecoline, pilocarpine, and 
physostigmine, were blocked primarily by the m choline+ antagonists and not signifi- 
cantly reduced by the n cholinergic antagonists, Mecamylamine actually enhanced the 
EEG desynchronizing effects of some m cholinergic agents. In contrast, neocortical 
activation due to nicotine was not signiflcantly affected by methyl atropine but was reduced 
to appro~mately half the duration by atropine. An interes~g dissociation between 
neocortical and limbic structures was observed following atropine pretreatment and 
subsequent nicotine administration. The results are similar to those reported by TORII 
and WIKLER (1964, 1966) for electrical stimulation of the midbrain reticular formation 
or posterior hypothalamus. It is well known that large doses of atropine effectively 
block neocortical activation due to a variety of stimuli or drugs (DOMINO and HUDSON, 
1958; WHITE and BCXAJY, 1959; and WHITE and DAUGNBAULT, 1959). This suggests that 
the terminal neurons for neocortical activation must involve m cholinergic synapses. 
The data of this study are consistent with the concept that there are important m and, 
to a less extent, n cholinergic receptor sites in EEG neocortical and limbic system activation. 
Furthermore, the initial effects of choline@ agonists are associated primarily with behavi- 
oral arousal. It has been reported previously by WIKLER (1952) and BRADLEY and ELKES 
(1957) and others that choliner~c an~go~s~ and agonists produce EEG dissociation 
from gross behavior. While similar findings were noted in the present study, it should 
be pointed out that effective doses of physostigmine and other cholinergic agonists produce 
initial clear-cut behavioral arousal. Furthermore, it should be pointed out that the findings 
of BRADLEY and ELKES (1957) and others with cholinergic agonists were made at a time 
when the stage of fast wave sleep was not generally appreciated. It would appear that 
in some instances investigators may have been observing fast wave sleep and did not recog- 
nize it. The findings of the present study strengthen the concept of a definite but not 
invariable relationship between EEG and behavior, especially during arousal from slow 
wave sleep. This relationship can be disrupted by atropine, for example. 
Jouvm (1961) reported that physostigmine increased the duration of fast wave sleep. 
In our experience the predominant effect of physosti~e was behavioral arousal and 
EEG activation. Only after 4 hr or more following physosti~e injection (during the 
recovery phase) was fast wave sleep seen. The total amount of fast wave sleep for 5Omin 
after physostigmine injection, however, was not significantly enhanced over that after 
saline solution. A particularly interesting tiding was that fast wave sleep could occur 
from an initial baseline of drowsiness. Pilocarpine produced a significant increase in 
the duration of fast wave sleep and the same phenomenon in which fast wave sleep was 
preceded by the resting or drowsy state rather than slow wave sleep. The findings of 
this study suggest an important role of cholinergic mechanisms in modulating some com- 
ponents of fast wave sleep. 
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